<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04242277</url>
  </required_header>
  <id_info>
    <org_study_id>PER-19-03</org_study_id>
    <nct_id>NCT04242277</nct_id>
  </id_info>
  <brief_title>Wide-field Optical Coherence Tomography Imaging of Excised Breast Tissue.</brief_title>
  <official_title>Wide-field Optical Coherence Tomography Imaging of Excised Breast Tissue for Evaluation of a Computer-aided Detection Tool, ImgAssistâ„¢.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Perimeter Medical Imaging</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Cancer Prevention Research Institute of Texas</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Perimeter Medical Imaging</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a single-arm, multi-center data collection study designed to collect WF-OCT imaging&#xD;
      data of excised breast tissue margins with corresponding margin status from histopathology.&#xD;
      Data collected during this study will be used for product development by the study sponsor,&#xD;
      Perimeter Medical Imaging.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 3, 2020</start_date>
  <completion_date type="Actual">July 27, 2021</completion_date>
  <primary_completion_date type="Actual">July 27, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>WF-OCT image acquisition of excised lumpectomy tissue margins</measure>
    <time_frame>1 year</time_frame>
    <description>This is a data collection study. The primary outcome is the collection of WF-OCT images of excised lumpectomy tissue margins.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">173</enrollment>
  <condition>Breast Cancer Female</condition>
  <arm_group>
    <arm_group_label>WF-OCT imaging of excised breast lumpectomy tissue</arm_group_label>
    <description>Excised lumpectomy tissue from all consented patients will be imaged on an investigational OCT-based device. No clinical decisions will be made based on the images acquired.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Investigational WF-OCT device</intervention_name>
    <description>Excised lumpectomy tissue will be imaged on an investigational WF-OCT device</description>
    <arm_group_label>WF-OCT imaging of excised breast lumpectomy tissue</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Consented patients meeting eligibility criteria, undergoing breast conservation surgery.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Female&#xD;
&#xD;
          -  Age 18 years or older&#xD;
&#xD;
          -  Invasive ductal breast carcinoma and ductal carcinoma in situ having undergone breast&#xD;
             conservation surgery&#xD;
&#xD;
          -  May include neo-adjuvant treated subjects (chemotherapeutic, endocrine therapy, or&#xD;
             radiation)&#xD;
&#xD;
          -  Ability to understand and the willingness to sign a written informed consent document&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Metastatic cancer (Stage IV)&#xD;
&#xD;
          -  Lobular carcinoma as primary diagnosis&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Savitri Krishnamurthy, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>M.D. Anderson Cancer Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Baylor College of Medicine</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>MD Anderson Cancer Center</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>January 23, 2020</study_first_submitted>
  <study_first_submitted_qc>January 23, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 27, 2020</study_first_posted>
  <last_update_submitted>October 6, 2021</last_update_submitted>
  <last_update_submitted_qc>October 6, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 7, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

